People
Filter News
Found 49,462 articles
-
BioSpace Movers & Shakers, Jan. 15
1/15/2021
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers and Shakers. -
Nadim Ahmed, president of hematology at BMS, is leaving the company to, according to “pursue other opportunities.”
-
Despite a storied career in drug design that has spanned multiple decades, James Woody believes there is still a significant amount of work left to be accomplished with the development of tumor necrosis factor inhibitor biologics.
-
Lexaria Appoints New Board Member
1/15/2021
Lexaria Bioscience Corp. , a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors.
-
Turret Capital Announces Dr. Mary Lake Polan To Join Board Of Directors Of Koi Therapeutics
1/15/2021
Turret Capital Management announced today that Dr. Mary Lake Polan has been appointed to the Board of Directors of its subsidiary company, Koi Therapeutics.
-
Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
1/15/2021
Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Henrietta Ukwu, M.D., FACP, FRAPS, to the position of Senior Vice President, Chief Regulatory and Quality Officer.
-
Tauriga Sciences Inc. Taking Immediate Steps to Strengthen its Board of Directors and Corporate Governance Protocols With Aim Towards Future Up-List to a National Stock Exchange
1/15/2021
Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that, in compliance with the Florida Business Corporations Act, and
-
The Alzheimer's Drug Discovery Foundation Announces New Additions to Board of Governors
1/15/2021
The Alzheimer's Drug Discovery Foundation (ADDF) announces two new members to its Board of Governors : Sharon T. Sager , CIMA, Managing Director and Private Wealth Advisor at UBS Private Wealth Management and Beatriz Illescas Putzeys-Claugus , Founder and Director of The Foundation for a Better World. They will help guide the ADDF in
-
Agilent Names Allison Ballmer Senior Vice President of Strategy and Corporate Development
1/15/2021
Agilent Technologies Inc.(NYSE: A) is pleased to announce Allison Ballmer has been named the company’s new senior vice president of Strategy and Corporate Development, reporting to Agilent President and CEO Mike McMullen. Ballmer will lead the corporate development team in identifying, developing, and evaluating merger-and-acquisition plans globally, as well as program management of integrations. She also will l
-
Fumiaki Ikeno, Medtech and Data Expert, Joins Omniscience as an Advisor
1/15/2021
Omniscience today announced that Fumiaki Ikeno, Program Director (U.S.) Japan Biodesign, Stanford Biodesign, Cardiovascular Medicine, Stanford University, has joined the company as an advisor
-
MediPharm Labs Appoints Warren Everitt, CEO Australia Pacific, to Board of Directors
1/15/2021
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced the appointment of Warren Everitt to its Board of Directors (the “Board”), effective immediately.
-
Therma Bright Adds Veteran Manufacturing Expert to Advisory Team to Advance its Saliva-Based Rapid Antigen Test CoviSafe(TM)
1/15/2021
Toronto, Ontario--(Newsfile Corp. - January 15, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce the appointment of Ian Levine to the advisory board to assist with future scaling for the manufacture of CoviSafe™.
-
Like many biopharma companies, the global COVID-19 pandemic has caused delays while also offering opportunities for NeuroRx.
-
Janet Woodcock, the longtime director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration is set to take over the top spot of the regulatory agency on an interim basis following the presidential inauguration of Joe Biden.
-
Billionaire entrepreneur Mark Cuban, best known as the owner of the Dallas Mavericks and an investor on the ABC business reality series “Shark Tank,” is diving into generic drugs with a new startup, dubbed Mark Cuban Cost Plus Drug Company.
-
Follica Adds Two Leaders in Aesthetic Medicine and Dermatology to Its Board of Directors
1/14/2021
Follica Inc., a biotechnology company developing a regenerative platform designed to treat androgenetic alopecia, epithelial aging and other related conditions, announced the appointment of two veteran biotech executives to its Board of Directors.
-
PureTech Founded Entity Follica Adds Two Leaders in Aesthetic Medicine and Dermatology to its Board of Directors
1/14/2021
PureTech Health plc is pleased to note that its Founded Entity, Follica, announced the appointment of two veteran biotech executives to its Board of Directors.
-
Sema4 Appoints Renowned Oncologist William Oh, M.D. as Chief Medical Science Officer
1/14/2021
Sema4, a patient-centered health intelligence company, today announced the appointment of William K. Oh, M.D., to the newly established senior leadership position of Chief Medical Science Officer
-
Cognoa Appoints Industry Veteran Eric B. Mosbrooker as Chief Operations Officer
1/14/2021
Cognoa, the leading pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with autism and other behavioral health conditions, today announced the appointment of Eric B. Mosbrooker as Chief Operations Officer.
-
Transgene Appoints Gaëlle Stadtler as Director of Human Resources
1/14/2021
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces the appointment of Gaëlle Stadtler as Director of Human Resources